Collaborative Research Centre 1009 Breaking Barriers - Welcome to our website

Infectious diseases and autoimmune or rheumatic disorders represent enormous medical and economic burdens to society. Common features of such inflammatory processes include their complexity and the frequent involvement of multiple organ systems. New strategies for therapy are urgently needed: Antibiotic therapy for infection is becoming increasingly restricted mainly due to the development of pathogen resistance, therapy against autoimmune and rheumatic diseases is still limited to mainly arbitrary suppression of inflammatory cytokines. Central to both infectious and inflammatory diseases are cellular barriers which, in physiological conditions, act to restrict pathogen entry and regulate immune cell surveillance of tissues. Uncontrolled breaching of such barriers is therefore fundamental to both infectious diseases as well as autoimmune and rheumatic disorders. This highlights the potential of targeting components of cellular barriers for future diagnostic, therapeutic or preventive strategies.

Second International Symposium „Autoinflammation breaks Barriers“

You can access a picture gallery as well as a press release about the second international symposium "Autoinflammation break Barriers" at this page.

Jour-Fixe Meetings of all SFB scientists

The Jour-Fixe meetings for all SFB scientists takes place on the 3rd Wednesday of every month at 5:00 pm c.t. in the auditorium of the Institute of Medical Microbiology. Guests are welcome. Please also read the respective thematic announcements in our appointment calendar.

Click here for detailled information.

Pioneers in Cell Dynamics and Imaging

International leading scientists will talk about their latest basic and clinical research findings in a new ring lecture. The lectures will take place on Mondays at 5:00 pm in the auditorium of the Institute of Physiological Chemistry and Pathobiochemistry, Waldeyerstrasse 15. This is an excellent oppurtunity to meet colleagues and exchange ideas. 

Click here for detailed information.